April 19, 2023
Toichi Takino, Executive Director, Discovery & Research, Ono Ono Pharmaceutical, having achieved success with its PD-1 inhibitor Opdivo (nivolumab), is focusing on open innovation in drug discovery and research activities to step up its game. Targeting therapeutic areas with highly...read more